• 1
    zur Hausen H. Papillomavirus infections—a major cause of human cancers. Biochim Biophys Acta. 1996; 1288: F5578.
  • 2
    Farthing A, Masterson P, Mason WP, Vousden KH. Human papillomavirus detection by hybrid capture and its possible clinical use. J Clin Pathol. 1994; 47: 649652.
  • 3
    Mitchell MF, Tortolero-Luna G, Wright T, et al. Cervical human papillomavirus infection and intraepithelial neoplasia: a review. J Natl Cancer Inst Monogr. 1996; 21: 1725.
  • 4
    Walboomers JM, Husman AM, Snijders PJ, et al. Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer. J Clin Pathol. 1995; 48: 728732.
  • 5
    Manos M, Lee K, Greer C, et al. Looking for human papillomavirus type 16 by PCR. Lancet. 1990; 335: 734.
  • 6
    Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol. 1990; 71: 173181.
  • 7
    Reid R, Lorincz AT. Human papillomavirus tests. Baillieres Clin Obstet Gynaecol. 1995; 9: 65103.
  • 8
    Brown DR, Bryan JT, Cramer H, Fife KH. Analysis of human papillomavirus types in exophytic condylomata acuminata by hybrid capture and Southern blot techniques. J Clin Microbiol. 1993; 31: 26672673.
  • 9
    Fife KH, Katz BP, Roush J, Handy VD, Brown DR, Hansell R. Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. Am J Obstet Gynecol. 1996; 174: 14871493.
  • 10
    Cavuslu S, Mant C, Starkey WG, et al. Analytic sensitivities of hybrid-capture, consensus and type-specific polymerase chain reactions for the detection of human papillomavirus type 16 DNA. J Med Virol. 1996; 49: 319324.
  • 11
    Cope JU, Hildesheim A, Schiffman MH, et al. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol. 1997; 35: 22622265.
  • 12
    Shah KV, Solomon L, Daniel R, Cohn S, Vlahov D. Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection. J Clin Microbiol. 1997; 35: 517519.
  • 13
    Melbye M, Smith E, Wohlfahrt J, et al. Anal and cervical abnormality in women—prediction by human papillomavirus tests. Int J Cancer. 1996; 68: 559564.
  • 14
    Poljak M, Brencic A, Seme K, Vince A, Marin IJ. Comparative evaluation of first- and second-generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer. J Clin Microbiol. 1999; 37: 796797.
  • 15
    Watanabe S, Kanda T, Yoshiike K. Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J Virol. 1989; 63: 965969.
  • 16
    zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology. 1991; 184: 913.
  • 17
    Jeon S, Lambert PF. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci USA. 1995; 92: 16541658.
  • 18
    Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 1993; 75: 495505.
  • 19
    Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989; 243: 934937.
  • 20
    Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 1989; 8: 39053910.
  • 21
    Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol. 1989; 63: 44174421.
  • 22
    Vousden KH, Vojtesek B, Fisher C, Lane D. HPV-16 E7 or adenovirus E1A can overcome the growth arrest of cells immortalized with a temperature-sensitive p53. Oncogene. 1993; 8: 16971702.
  • 23
    Cornelissen MT, Smits HL, Briet MA, et al. Uniformity of the splicing pattern of the E6/E7 transcripts in human papillomavirus type 16-transformed human fibroblasts, human cervical premalignant lesions and carcinomas. J Gen Virol. 1990; 71: 12431246.
  • 24
    von Knebel Doeberitz M, Oltersdorf T, Schwarz E, Gissmann L. Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res. 1988; 48: 37803786.
  • 25
    Rose BR, Thompson CH, Tattersall MH, Elliott PM, Dalrymple C, Cossart YE. Identification of E6/E7 transcription patterns in HPV 16-positive cervical cancers using the reverse transcription/polymerase chain reaction. Gynecol Oncol. 1995; 56: 239244.
  • 26
    Rose BR, Thompson CH, Jiang XM, et al. Detection of human papillomavirus type 16 E6/E7 transcripts in histologically cancer-free pelvic lymph nodes of patients with cervical carcinoma. Gynecol Oncol. 1994; 52: 212217.
  • 27
    Wang-Johanning F, Frost AR, Johanning GL, et al. Expression of human endogenous retrovirus K envelope transcripts in human breast cancer. Clin Cancer Res. 2001; 7: 15531560.
  • 28
    Wang-Johanning F, Gillespie GY, Grim J, et al. Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects. Cancer Res. 1998; 58: 18931900.
  • 29
    Pillai MR, Halabi S, McKalip A, et al. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. Cancer Epidemiol Biomarkers Prev. 1996; 5: 329335.
  • 30
    Auvinen E, Kujari H, Arstila P, Hukkanen V. Expression of the L2 and E7 genes of the human papillomavirus type 16 in female genital dysplasias. Am J Pathol. 1992; 141: 12171224.
  • 31
    Schwarz E, Freese UK, Gissmann L, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 1985; 314: 111114.
  • 32
    Yutsudo M, Okamoto Y, Hakura A. Functional dissociation of transforming genes of human papillomavirus type 16. Virology. 1988; 166: 594597.
  • 33
    Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990; 248: 7679.
  • 34
    Crook T, Tidy JA, Vousden KH. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell. 1991; 67: 547556.
  • 35
    de Villiers EM, Wagner D, Schneider A, et al. Human papillomavirus DNA in women without and with cytological abnormalities: results of a 5-year follow-up study. Gynecol Oncol. 1992; 44: 3339.
  • 36
    Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993; 85: 958964.
  • 37
    Bernard C, Mougin C, Laurent R, Lab M. Oncogene activation: an informative marker for the human papillomavirus lesions severity. Cancer Detect Prev. 1994; 18: 273282.
  • 38
    de Roda Husman AM, Walboomers JM, Meijer CJ, et al. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer. 1994; 56: 802806.
  • 39
    Forslund O, Lindqvist P, Haadem K, Czegledy J, Hansson BG. HPV 16 DNA and mRNA in cervical brush samples quantified by PCR and microwell hybridization. J Virol Methods. 1997; 69: 209222.
  • 40
    Nakagawa S, Yoshikawa H, Yasugi T, et al. Ubiquitous presence of E6 and E7 transcripts in human papillomavirus-positive cervical carcinomas regardless of its type. J Med Virol. 2000; 62: 251258.
  • 41
    Sotlar K, Selinka HC, Menton M, Kandolf R, Bultmann B. Detection of human papillomavirus type 16 E6/E7 oncogene transcripts in dysplastic and nondysplastic cervical scrapes by nested RT-PCR. Gynecol Oncol. 1998; 69: 114121.
  • 42
    Fujii T, Tsukazaki K, Kiguchi K, Kubushiro K, Yajima M, Nozawa S. The major E6/E7 transcript of HPV-16 in exfoliated cells from cervical neoplasia patients. Gynecol Oncol. 1995; 58: 210215.
  • 43
    Dimulescu II, Unger ER, Lee DR, Reeves WC, Vernon SD. Characterization of RNA in cytologic samples preserved in a methanol-based collection solution. Mol Diagn. 1998; 3: 6771.
  • 44
    Tucker RA, Unger ER, Holloway BP, Swan DC. Real-time PCR-based fluorescent assay for quantitation of human papillomavirus types 6, 11, 16, and 18. Mol Diagn. 2001; 6: 3947.
  • 45
    Cubie HA, Seagar AL, McGoogan E, et al. Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18. Mol Pathol. 2001; 54: 2429.
  • 46
    Song S, Liem A, Miller JA, Lambert PF. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology. 2000; 267: 141l50.